Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

  • Alexander S. Pym
  • , Priscille Brodin
  • , Laleh Majlessi
  • , Roland Brosch
  • , Caroline Demangel
  • , Ann Williams
  • , Karen E. Griffiths
  • , Gilles Marchal
  • , Claude Leclerc
  • , Stewart T. Cole*
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    576 Citations (Scopus)

    Abstract

    The live tuberculosis vaccines Mycobacterium bovis BCG (bacille Calmette-Guérin) and Mycobacterium microti both lack the potent, secreted T-cell antigens ESAT-6 (6-kDa early secretory antigenic target) and CFP-10 (10-kDa culture filtrate protein). This is a result of independent deletions in the region of deletion-1 (RD1) locus, which is intact in virulent members of the Mycobacterium tuberculosis complex. To increase their immunogenicity and protective capacity, we complemented both vaccines with different constructs containing the esxA and esxB genes, which encode ESAT-6 and CFP-10 respectively, as well as a variable number of flanking genes. Only reintroduction of the complete locus, comprising at least 11 genes, led to full secretion of the antigens and resulted in specific ESAT-6-dependent immune responses; this suggests that the flanking genes encode a secretory apparatus. Mice and guinea pigs vaccinated with the recombinant strain BCG::RD1-2F9 were better protected against challenge with M. tuberculosis, showing less severe pathology and reduced dissemination of the pathogen, as compared with control animals immunized with BCG alone.

    Original languageEnglish
    Pages (from-to)533-539
    Number of pages7
    JournalNature Medicine
    Volume9
    Issue number5
    DOIs
    Publication statusPublished - 1 May 2003

    Bibliographical note

    Funding Information:
    Acknowledgments We thank P. Chavarot, S.V. Gordon, M. Huerre, H. Khun, E. Maranghi, M. Marmiesse, P. Sebo and D. van Soolingen for advice, support, reagents and sharing of data. This work was funded by the Wellcome Trust, the Institut Pasteur (PTR110), the European Community (QLK2-CT1999-01093) and the Association Française Raoul Follereau. A.S.P. has a Wellcome Trust Training Fellowship in Clinical Tropical Medicine. This paper is dedicated to the memory of M.J. Colston.

    Fingerprint

    Dive into the research topics of 'Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis'. Together they form a unique fingerprint.

    Cite this